Login

Christophe INIZAN of La Française AM discusses European commercial real estate investment strategies. 00:10:00

Share On Facebook Share On Twitter

Guillaume CADIOU is Chairman of La Française Group

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Aura Energy - Uranium and Vanadium Projects
00:10:00
Summary and Analysis of Nova Royalty's Strategy and Market Position
00:10:00
August Market Insights: Volatility, Politics, and Investment Opportunities
00:10:00
CFO Hanna Franzén Discusses Heba Real Estate’s Future | Hanna Franzén, CFO, Heba Real Estate AB.
00:10:00
Understanding the Four Pillars of Capital: Insights from Caspar Helmore | Caspar Helmore, Partner - Client Management
00:10:00
Alex Kroes: Suspension, Van Praag, and His New Role at Ajax | Alex Kroes, CEO, AFC Ajax N.V.
00:10:00
"Global and Emerging Markets Outlook with Mark Mobius | Voyage 2022"
00:00:00
Eric Poma, CEO of Molecular Templates
00:10:00
Invests in world-class entrepreneurs at the earliest stages and support them|Wesley Barton,Managing Partner,Third Prime
00:10:00
3U HOLDING AG - Annual review 2019 | Christoph Hellrung, CFO, 3U Holding AGUUUX:GER
00:10:00
We are devoted to our clients and it's reflected by our tenure, scale, and recognition as the industry's fastest growing target date suite. Our dedication to clients is matched by our commitment to our community. flexPATH Strategies is pleased to fundrais
00:00:00
Michael Johnson, CEO, Rhinomed Ltd

© 2017 - Neuhu+